Laboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, 632014, Tamil Nadu, India.
Department of Integrative Biology, College of Arts and Sciences, University of South Florida, St. Petersburg, Florida, 33701, USA.
Funct Integr Genomics. 2023 May 27;23(2):184. doi: 10.1007/s10142-023-01083-3.
Circular RNAs (circRNAs) are regulatory elements that are involved in orchestrating gene expression and protein functions and are implicated in various biological processes including cancer. Notably, breast cancer has a significant mortality rate and is one of the most common malignancies in women. CircRNAs have been demonstrated to contribute to the pathogenesis of breast cancer including its initiation, progression, metastasis, and resistance to drugs. By acting as miRNA sponges, circRNAs can indirectly influence gene expression by disrupting miRNA regulation of their target genes, ultimately altering the course of cancer development and progression. Additionally, circRNAs can interact with proteins and modulate their functions including signaling pathways involved in the initiation and development of cancer. Recently, circRNAs can encode peptides that play a role in the pathophysiology of breast cancer and other diseases and their potential as diagnostic biomarkers and therapeutic targets for various cancers including breast cancer. CircRNAs possess biomarkers that differentiate, such as stability, specificity, and sensitivity, and can be detected in several biological specimens such as blood, saliva, and urine. Moreover, circRNAs play an important role in various cellular processes including cell proliferation, differentiation, and apoptosis, all of which are integral factors in the development and progression of cancer. This review synthesizes the functions of circRNAs in breast cancer, scrutinizing their contributions to the onset and evolution of the disease through their interactions with exosomes and cancer-related intracellular pathways. It also delves into the potential use of circRNA as a biomarker and therapeutic target against breast cancer. It discusses various databases and online tools that offer crucial circRNA information and regulatory networks. Lastly, the challenges and prospects of utilizing circRNAs in clinical settings associated with breast cancer are explored.
环状 RNA(circRNAs)是参与调控基因表达和蛋白质功能的调节因子,与包括癌症在内的各种生物学过程有关。值得注意的是,乳腺癌死亡率高,是女性中最常见的恶性肿瘤之一。circRNAs 已被证明参与乳腺癌的发病机制,包括其起始、进展、转移和对药物的耐药性。circRNAs 作为 miRNA 海绵,可以通过干扰 miRNA 对其靶基因的调节,间接影响基因表达,最终改变癌症发展和进展的进程。此外,circRNAs 可以与蛋白质相互作用并调节其功能,包括参与癌症起始和发展的信号通路。最近,circRNAs 可以编码在乳腺癌和其他疾病的病理生理学中发挥作用的肽,它们作为各种癌症(包括乳腺癌)的诊断生物标志物和治疗靶点具有潜力。circRNAs 具有区分标志物的特性,例如稳定性、特异性和敏感性,并可以在几种生物样本中检测到,如血液、唾液和尿液。此外,circRNAs 在细胞增殖、分化和凋亡等各种细胞过程中发挥重要作用,所有这些都是癌症发展和进展的重要因素。本综述综合了 circRNAs 在乳腺癌中的功能,通过其与外泌体和癌症相关的细胞内途径的相互作用,探讨了它们对疾病发生和演变的贡献。还探讨了 circRNA 作为乳腺癌生物标志物和治疗靶点的潜在用途。讨论了提供关键 circRNA 信息和调控网络的各种数据库和在线工具。最后,探讨了在与乳腺癌相关的临床环境中利用 circRNAs 所面临的挑战和前景。